SCHEMBL19861220

SCHEMBL19861220

CCCCCCC(C)(C)CCCCCC(=O)O

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 7/20 0.71
PPARG P37231 7/20 0.71
PPARD Q03181 7/20 0.71
PPARA Q07869 7/20 0.71
HDAC11 Q96DB2 5/20 0.71
TSHR P16473 4/20 0.71
PTPN1 P18031 3/20 0.71
FABP4 P15090 3/20 0.71
ALDH1A1 P00352 2/20 0.71
TLR2 O60603 2/20 0.71
TDP1 Q9NUW8 2/20 0.71
KMT2A Q03164 2/20 0.71
ALOX15 P16050 2/20 0.71
HSD17B10 Q99714 2/20 0.71
SLC22A6 Q4U2R8 1/20 0.71
SLC22A8 Q8TCC7 1/20 0.71
MEN1 O00255 1/20 0.71
ESR1 P03372 1/20 0.71
PDE4A P27815 1/20 0.71
PDE3A Q14432 1/20 0.71

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19861428 1.00 GPR84 (0.71) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL8039123 1.00 GPR84 (0.71) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL20076148 1.00 GPR84 (0.71) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL5878877 1.00 GPR84 (0.71) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL28415946 1.00 GPR84 (0.71) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL19861449 0.96 GPR84 (0.64) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL19861306 0.96 GPR84 (0.64) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL24443498 0.92 GPR84 (0.58) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL1116131 0.92 GPR84 (0.58) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL20047565 0.92 GPR84 (0.58) GPR84PPARGPPARDPPARAHDAC11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10647747-B2 Cyclosporin derivatives and uses thereof S&T GLOBAL INC. (US) 2020-05-12 US disclosed
US-20180105558-A1 NOVEL CYCLOSPORIN DERIVATIVES AND USES THEREOF S&T GLOBAL INC. 2018-04-19 US disclosed
US-9890198-B2 Cyclosporin derivatives and uses thereof S&T GLOBAL INC. (US) 2018-02-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10647747-B2 Cyclosporin derivatives and uses thereof FKBP5, FKBP1B, MALT1 GPR84 4413/4885PPARG 3405/4885PPARD 1878/4885
US-20180105558-A1 NOVEL CYCLOSPORIN DERIVATIVES AND USES THEREOF FKBP1B, MALT1, FKBP5 GPR84 3935/4885PPARG 3367/4885PPARD 2011/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.